Tivozanib versus sorafenib as initial targeted therapy for patients with advanced renal cell carcinoma: Results from a Phase III randomized, open-label, multicenter trial Meeting Abstract
| Authors: | Motzer, R.; Nosov, D.; Eisen, T.; Bondarenko, I.; Lesovoy, V.; Lipatov, O.; Tomczak, P.; Lyulko, O.; Alyasova, A.; Harza, M.; Kogan, M.; Alexeev, B. Y.; Sternberg, C. N.; Szczylik, C.; Zhang, J.; Strahs, A.; Esteves, B.; Slichenmyer, W.; Berkenblit, A.; Hutson, T. E. |
| Abstract Title: | Tivozanib versus sorafenib as initial targeted therapy for patients with advanced renal cell carcinoma: Results from a Phase III randomized, open-label, multicenter trial |
| Meeting Title: | 11th International Kidney Cancer Symposium |
| Journal Title: | BJU International |
| Volume: | 110 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2012 Oct 5-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 1464-4096 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2012-01-01 |
| Start Page: | 14 |
| Language: | English |
| ACCESSION: | WOS:000308932400031 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract: 30 - 11th International Kidney Cancer Symposium - OCT 05-06, 2012 - Chicago, IL - "2" - SI - "Source: Wos" |
MSK Authors
-
1243Motzer